CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Activities
Net (loss) income	$ (285,415)	$ 13,416
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation, depletion and amortization	41,527	14,934
Accounts Receivable, Credit Loss Expense (Reversal)	2,998	(110)
Provision for inventory obsolescence	16,449	1,201
Restructuring expenses	6,091	0
Stock-based compensation expense	8,354	5,006
Non-cash operating lease expense	9,751	5,660
Impairment charges	192,328	0
Change in fair value of contingent consideration	(1,560)	(2,610)
Deferred income tax benefit	(9,310)	(20,996)
Other	1,210	1,364
Changes in assets and liabilities:
Accounts receivable	16,665	(1,926)
Inventories	57,023	(46,849)
Prepaid expenses and other current assets	3,663	2,761
Other assets	262	(1,781)
Accounts payable	(11,998)	(12,303)
Accrued expenses and other current liabilities	(4,532)	(3,238)
Deferred revenue	(13,297)	5,080
Lease liabilities	(7,850)	(4,676)
Other long-term liabilities	(370)	0
Net cash provided by (used in) operating activities	21,989	(45,067)
Investing activities
Business combinations, net of cash and cash equivalents	190	(462,172)
Capital expenditures of property, plant and equipment	(8,229)	(5,402)
Other	(448)	(610)
Net cash used in investing activities	(8,487)	(468,184)
Financing activities
Proceeds from issuance of common stock upon follow-on public offering, net of offering costs	0	309,782
Proceeds from exercises of investor warrants	0	56,778
Payment of withholding tax related to restricted stock units	(2,470)	(20,025)
Borrowings under revolving credit facilities	853	142,628
Repayments of revolving credit facilities	(1,102)	(143,003)
Repayments of Term Loan	(1,250)	0
Proceeds from issuance of Term Loan, net of discount and issuance costs	0	119,879
Payments to settle contingent consideration	(15,474)	0
Other	(757)	(1,332)
Net cash (used in) provided by financing activities	(20,200)	464,707
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(395)	(27)
Net decrease in cash, cash equivalents and restricted cash	(7,093)	(48,571)
Cash, cash equivalents and restricted cash at beginning of year	28,384	76,955
Cash, cash equivalents and restricted cash at end of year	21,291	28,384
Non-cash investing and financing activities
Issuance of common stock as consideration in connection with business combinations	0	53,611
Increase in accrued expenses and other current liabilities for contingent consideration	0	19,644
Right-of-use assets acquired under operating lease obligation	28,972	22,873
Supplemental information
Cash paid for interest	9,643	1,621
Cash paid for income taxes	$ 3,906	$ 1,963